T-cell subsets and antifungal host defenses

Current Fungal Infection Reports

Volumn 4, Issue 4, 2010, Pages 238-243

  Van De Veerdonk, Frank L ^a   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adaptive immunity; Aspergillus; Candida; Cryptococcus; Cytokine responses; Cytotoxic T cells; Fungal infection; Gamma delta T cells; Histoplasma; IL 10; IL 17; IL 4; Interaction; Interferon gamma; Plasticity; Pneumocystis; Regulatory T cells; T helper cells; Th1; Th17; Th2

Indexed keywords

CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; FUNGUS; GAMMA DELTA T LYMPHOCYTE; HOST RESISTANCE; HUMAN; IMMUNOREGULATION; MYCOSIS; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

EID: 79952185969     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-010-0034-6     Document Type: Review

References (51)

1. Mosmann TR, Coffman RL: TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173. (Pubitemid 19138011)
2. Balish E, Wagner RD, Vasquez-Torres A, et al.: Candidiasis in interferon-gamma knock-out (IFN-gamma-/-) mice. J Infect Dis 1998, 178:478-487. (Pubitemid 28347932)
3. Netea MG, Vonk AG, van den Hoven M, et al.: Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection. Eur J Immunol 2003, 33:3409-3417. (Pubitemid 37541118)
4. Kaposzta R, Tree P, Marodi L, Gordon S: Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 1998, 66:1708-1717. (Pubitemid 128471538)
5. Rivera A, Van Epps HL, Hohl TM, et al.: Distinct CD4+-T-cell responses to live and heat-inactivated Aspergillus fumigatus conidia. Infect Immun 2005, 73:7170-7179. (Pubitemid 41587614)
6. Rivera A, Ro G, Van Epps HL, et al.: Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity 2006, 25:665-675. (Pubitemid 44529034)
7. Bozza S, Perruccio K, Montagnoli C, et al.: A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation. Blood 2003, 102:3807-14. (Pubitemid 37409405)
8. Cenci E,Mencacci A, Bacci A, et al.: T cell vaccination in mice with invasive pulmonary aspergillosis. J Immunol 2000, 165:381-388. (Pubitemid 30429530)
9. Hebart H, Bollinger C, Fisch P, et al.: Analysis of T-cell responses to Aspergillus fumigatus antigens in healthy individuals and patients with hematologic malignancies. Blood 2002, 100:4521-4528. (Pubitemid 35429693)
10. Chen GH, McDonald RA, Wells JC, et al.: The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans. Infect Immun 2005, 73:1788-1796. (Pubitemid 40470768)
11. Zhang Y, Wang F, Tompkins KC, et al.: Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol 2009, 175:2489-2500.
12. Scheckelhoff M, Deepe GS Jr: A deficiency in gamma interferon or interleukin-10 modulates T-cell-dependent responses to heat shock protein 60 from Histoplasma capsulatum. Infect Immun 2005, 73:2129-2134. (Pubitemid 40470812)
13. Huang W, Na L, Fidel PL, Schwarzenberger P: Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 2004, 190:624-631. (Pubitemid 38982105)
14. Conti HR, Shen F, Nayyar N, et al.: Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206:299-311. This article describes the importance of the Th17 lineage, acting largely through IL-17, in the response to oral candidiasis by recruiting neutrophils and inducing antimicrobial factors.
15. Saijo S, Ikeda S, Yamabe K, et al.: Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010, 32:681-691. This study reports that dectin-2 is important in the host defense against disseminated candidiasis by inducing Th17 cell differentiation.
16. Zelante T, De Luca A, Bonifazi P, et al.: IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007, 37:2695-2706. (Pubitemid 47578289)
17. Bozza S, Zelante T, Moretti S, et al.: Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol 2008, 180:4022-4031.
18. Eyerich K, Foerster S, Rombold S, et al.: Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 2008, 128:2640-2645. This paper describes for the first time the presence of a Th17 defect in patients with chronic mucocutaneous candidiasis.
19. Grimbacher B, Holland SM, Gallin JI, et al.: Hyper-IgE syndrome with recurrent infections - an autosomal dominant multisystem disorder. N Engl J Med 1999, 340:692-702. (Pubitemid 29110753)
20. Glocker EO, Hennigs A, Nabavi M, et al.: A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009, 361:1727-1735. This paper describes for the first time a family with CARD9 deficiency. CARD9 deficiency was found to be associated with an increased susceptibility to chronic mucocutaneous candidiasis.
21. Ferwerda B, Ferwerda G, Plantinga TS, et al.: Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009, 361:1760-1767. This is the first report of a family with dectin-1 deficiency. This study highlights the specific role of dectin-1 in human mucosal antifungal defense.
22. Romani L, Fallarino F, De Luca A, et al.: Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008, 451:211-215.
23. Chai LY, van de Veerdonk F, Marijnissen RJ, et al.: Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology 2010, 130:46-54.
24. Rudner XL, Happel KI, Young EA, Shellito JE: Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007, 75:3055-3061. (Pubitemid 46870190)
25. Kleinschek MA, Muller U, Brodie SJ, et al.: IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 2006, 176:1098-1106. (Pubitemid 43099711)
26. Loures FV, Pina A, Felonato M, Calich VL: TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 2009, 183:1279-1290.
27. Kroetz DN, GS Jr: CCR5 dictates the equilibrium of proinflammatory IL-17(+) and regulatory Foxp3(+) T cells in fungal infection. J Immunol 2010, 184:5224-5231.
28. Romani L: Immunity to fungal infections. Nat Rev Immunol 2004, 4:1-13.
29. Leigh JE, Steele C, Wormley FL Jr, et al.: Th1/Th2 cytokine expression in saliva of HIV-positive and HIV-negative individuals: a pilot study in HIV-positive individuals with oropharyngeal candidiasis. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19:373-380. (Pubitemid 28536046)
30. Haraguchi N, Ishii Y, Morishima Y, et al.: Impairment of host defense against disseminated candidiasis in mice overexpressing GATA-3. Infect Immun 2010, 78:2302-2311.
31. Luong A, Davis LS,Marple BF: Peripheral blood mononuclear cells from allergic fungal rhinosinusitis adults express a Th2 cytokine response to fungal antigens. AmJ Rhinol Allergy 2009, 23:281-287.
32. Cenci E, Mencacci A, Del Sero G, et al.: Interleukin-4 causes susceptibility to invasive pulmonary aspergillosis through suppression of protective type I responses. J Infect Dis 1999, 180:1957-1968.
33. Mednick AJ, Nosanchuk JD, Casadevall A: Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect Immun 2005, 73:2012-2019. (Pubitemid 40470799)
34. Hernandez Y, Arora S, Erb-Downward JR, et al.: Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol 2005, 174:1027-1036. (Pubitemid 40094299)
35. Stenzel W, Muller U, Kohler G, et al.: IL-4/IL-13-dependent alternative activation of macrophages but not microglial cells is associated with uncontrolled cerebral cryptococcosis. Am J Pathol 2009, 174:486-496.
36. Gildea LA, Gibbons R, Finkelman FD, Deepe GS Jr: Overexpression of interleukin-4 in lungs of mice impairs elimination of Histoplasma capsulatum. Infect Immun 2003, 71:3787-3793. (Pubitemid 36753700)
37. Netea MG, Sutmuller R, Hermann C, et al.: Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J Immunol 2004, 172:3712-3718. (Pubitemid 38337955)
38. Sutmuller RP, den Brok MH, Kramer M, et al.: Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006, 116:485-494. (Pubitemid 43228366)
39. Vignali DA, Collison LW, Workman CJ: How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
40. De Luca A, Montagnoli C, Zelante T, et al.: Functional yet balanced reactivity to Candida albicans requires TRIF, MyD88, and IDO-dependent inhibition of Rorc. J Immunol 2007, 179:5999-6008.
41. Montagnoli C, Fallarino F, Gaziano R, et al.: Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 2006, 176:1712-1723. (Pubitemid 43134316)
42. McKinley L, Logar AJ, McAllister F, et al.: Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of Pneumocystis pneumonia. J Immunol 2006, 177:6215-6226. (Pubitemid 44628840)
43. Beno DW, Stover AG, Mathews HL: Growth inhibition of Candida albicans hyphae by CD8+ lymphocytes. J Immunol 1995, 154:5273-5281.
44. Marquis M, Lewandowski D, Dugas V, et al.: CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1. Infect Immun 2006, 74:2382-2391.
45. Lindell DM, Moore TA, McDonald RA, et al.: Generation of antifungal effector CD8+ T cells in the absence of CD4+ T cells during Cryptococcus neoformans infection. J Immunol 2005, 174:7920-7928. (Pubitemid 40806302)
46. McAllister F, Steele C, Zheng M, et al.: T cytotoxic-1 CD8+ T cells are effector cells against Pneumocystis in mice. J Immunol 2004, 172:1132-1138. (Pubitemid 38113773)
47. Fenoglio D, Poggi A, Catellani S, et al.: Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 2009, 113:6611-6618.
48. Jones-Carson J, Vazquez-Torres A, van der Heyde HC, et al.: Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat Med 1995, 1:552-557.
49. Wormley FL Jr, Steele C, Wozniak K, et al.: Resistance of T-cell receptor delta-chain-deficient mice to experimental Candida albicans vaginitis. Infect Immun 2001, 69:7162-7164. (Pubitemid 32995479)
50. Mannoor MK, Weerasinghe A, Halder RC, et al.: Resistance to malarial infection is achieved by the cooperation of NK1.1(+) and NK1.1(-) subsets of intermediate TCR cells which are constituents of innate immunity. Cell Immunol 2001, 211:96-104. (Pubitemid 32977340)
51. Munk ME, Fazioli RA, Calich VL, Kaufmann SH: Paracoccidioides brasiliensis-stimulated human gamma/delta T cells support antibody production by B cells. Infect Immun 1995, 63:1608-1610.